logo

For the Inventor, By the Inventor

Palo Alto, CA, United States of America

Kodiak Sciences Inc.

Calculating rank
USPTO Granted Patents = 14

% Expired Patents = 7.1


Forward Citations = 65

Loading Chart...
Loading Chart...

25 inventors (with patents filed for the assignee):

goldMedal Daniel Victor Perlroth (10 out of 10 patents)

silverMedal Wayne To (8 out of 18 patents)

bronzeMedal Stephen A Charles (8 out of 22 patents)

4.  Didier G Benoit (7 out of 16 patents)

5.  Hong Liang (6 out of 11 patents)

6.  James Bradley Aggen (5 out of 51 patents)

7.  Martin Sheringham Linsell (5 out of 82 patents)

8.  D Victor Perlroth (4 out of 7 patents)

9.  Wah Yuen To (3 out of 3 patents)

10.  Li Song (3 out of 6 patents)

11.  Fernando Corrêa (3 out of 3 patents)

12.  Lidia Mosyak (2 out of 16 patents)

13.  Laura Lin (2 out of 11 patents)

14.  Justin Cohen (2 out of 3 patents)

15.  Tetsuya Ishino (2 out of 7 patents)


14 patents:

1. 12643958 - METHODS OF TREATING AN EYE DISORDER (2026-06-02),
2. 12466879 - COMPLEMENT FACTOR D ANTAGONIST ANTIBODIES AND CONJUGATES THEREOF (2025-11-11),
3. 12214044 - Factor VIII zwitterionic polymer conjugates (2025-02-04),
4. 12071476 - IL-6 antibodies and fusion constructs and conjugates thereof (2024-08-27),
5. 11912784 - Methods of treating an eye disorder (2024-02-27),
6. 11819531 - Multifunctional zwitterionic polymer conjugates (2023-11-21),
7. 11590235 - Factor VIII zwitterionic polymer conjugates (2023-02-28),
8. 11584790 - Complement factor D antagonist antibodies and conjugates thereof (2023-02-21),
9. 11155610 - Dual PDGF/VEGF antagonists (2021-10-26),
10. 11071771 - Butyrylcholinesterase zwitterionic polymer conjugates (2021-07-27),
11. 11066465 - Antibodies and conjugates thereof (2021-07-20),
12. 10702608 - Factor VIII zwitterionic polymer conjugates (2020-07-07),
13. 10363290 - Butyrylcholinesterase zwitterionic polymer conjugates (2019-07-30),
14. 9840553 - Dual PDGF/VEGF antagonists (2017-12-12),
Company Overview
Kodiak Sciences Inc. is a biopharmaceutical company based in Palo Alto, California, focused on developing innovative therapies for retinal diseases. The company specializes in advancing novel biologics aimed at improving vision and addressing unmet medical needs in ophthalmology. With a commitment to scientific excellence, Kodiak leverages cutting-edge research and technology to create transformative treatments that enhance patient outcomes and quality of life in the field of eye care.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

14 Patents

#126 in Palo Alto, CA

#5,322 in California

#22,333 in US

#42,290 in the World

Palo Alto, CA (US)
Palo Alto, CA, United States of America

Kodiak Sciences Inc.

Forward Citations = 65

25 inventors:

goldMedal Daniel Victor Perlroth (10 out of 10 patents)

silverMedal Wayne To (8 out of 18 patents)

bronzeMedal Stephen A Charles (8 out of 22 patents)

4.  Didier G Benoit (7 out of 16 patents)

5.  Hong Liang (6 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kodiak Sciences Inc.. Retrieved from https://idiyas.com/company/kodiak-sciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…